News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2025 Caitlin E. Cox November 03, 2025
News Conference News TCT 2025 Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC Yael L. Maxwell October 27, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News Money Talk: Cardiologists Must Weigh Costs as Transcatheter Therapies Ascend Caitlin E. Cox August 11, 2025
News Conference News NY Valves 2025 Solid, Early Surgical Results With Polymer Mitral Valve Todd Neale July 02, 2025
News Conference News NY Valves 2025 Good Outcomes, Little Hospital Experience: Pascal TEER in Real World Yael L. Maxwell June 30, 2025
News Conference News THT 2025 Positive Results With Carillon Mitral Device Seen in Real-world Registries Todd Neale February 21, 2025
News Conference News EACTS 2024 AI-Based CT Can Accurately Screen Patients for TMVR Yael L. Maxwell October 15, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2024 Caitlin E. Cox September 03, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Conference News PCR London Valves 2023 EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling Shelley Wood November 28, 2023
News Daily News Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry Michael O'Riordan September 27, 2023
News Daily News Women and Minorities Underrepresented in Heart Valve Trials L.A. McKeown July 27, 2023
News Conference News TVT 2023 Latest-Generation MitraClip Devices Make Strides Against Residual MR Shelley Wood June 09, 2023
News Conference News EuroPCR 2023 Transcatheter MV Replacement vs Best Medical Therapy? Some Clues Shelley Wood May 17, 2023
News Daily News Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research Yael L. Maxwell December 12, 2022
News Daily News COAPT Risk Score Useful in Predicting Outcomes in Functional MR Michael O'Riordan October 05, 2022